http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1342643-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1845a3df7b600cb98c6ab12e7d28769
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-84
filingDate 1971-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f990b2bcf00a519df1cf3f6b6f732598
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97afb95a24348beb227658d3a359a0fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_407082cac430710b451e5fd9b46fc75c
publicationDate 1974-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1342643-A
titleOfInvention Thioacetanilide derivatives
abstract 1342643 Imidazolin- 2 - ylthio - acetanilides WANDER Ltd 19 April 1971 [3 Feb 1970] 20644/71 Heading C2C Novel compounds (I) (including salts thereof) where R 1 and R 2 are H, halogen or C 1 to C 3 alkyl and R 3 and R 4 are both H or one of R 3 and R 4 is C 1 to C 3 alkyl or OH and the other is H are made by interacting (II) and (III). Pharmaceutical preparations acting as antihypertensive contain (I) as active ingredient; administration may be orally or parenterally.
priorityDate 1970-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154357022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416088990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432454693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID820777

Total number of triples: 19.